| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Resynchronization Therapy | 41 | 2024 | 74 | 13.140 |
Why?
|
| Bundle-Branch Block | 25 | 2024 | 55 | 8.100 |
Why?
|
| Bundle of His | 22 | 2024 | 46 | 7.930 |
Why?
|
| Electrocardiography | 33 | 2024 | 497 | 5.750 |
Why?
|
| Defibrillators, Implantable | 22 | 2024 | 146 | 5.700 |
Why?
|
| Heart Failure | 30 | 2024 | 1253 | 5.100 |
Why?
|
| Atrial Fibrillation | 18 | 2024 | 357 | 4.630 |
Why?
|
| Tachycardia, Ventricular | 18 | 2024 | 124 | 3.720 |
Why?
|
| Catheter Ablation | 22 | 2024 | 254 | 3.070 |
Why?
|
| Cardiac Pacing, Artificial | 17 | 2024 | 103 | 2.600 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 11 | 2024 | 54 | 1.980 |
Why?
|
| Heart Conduction System | 14 | 2023 | 112 | 1.850 |
Why?
|
| Arrhythmias, Cardiac | 14 | 2024 | 200 | 1.820 |
Why?
|
| Heart Rate | 11 | 2024 | 498 | 1.690 |
Why?
|
| Heart Ventricles | 14 | 2020 | 786 | 1.500 |
Why?
|
| Treatment Outcome | 47 | 2024 | 8292 | 1.470 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 7 | 2019 | 19 | 1.250 |
Why?
|
| Pacemaker, Artificial | 7 | 2024 | 96 | 1.180 |
Why?
|
| Humans | 109 | 2024 | 90014 | 1.140 |
Why?
|
| Electric Countershock | 4 | 2024 | 55 | 1.100 |
Why?
|
| Aged | 55 | 2024 | 19272 | 1.020 |
Why?
|
| Stroke Volume | 4 | 2024 | 479 | 0.960 |
Why?
|
| Death, Sudden, Cardiac | 5 | 2024 | 54 | 0.950 |
Why?
|
| Anti-Arrhythmia Agents | 3 | 2019 | 65 | 0.950 |
Why?
|
| Heart Septum | 3 | 2024 | 47 | 0.890 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 3 | 2020 | 23 | 0.870 |
Why?
|
| Cardiomyopathies | 7 | 2020 | 267 | 0.850 |
Why?
|
| Body Surface Potential Mapping | 5 | 2021 | 25 | 0.840 |
Why?
|
| Middle Aged | 44 | 2024 | 26173 | 0.820 |
Why?
|
| Echocardiography | 9 | 2019 | 944 | 0.820 |
Why?
|
| Mitral Valve Insufficiency | 4 | 2019 | 196 | 0.800 |
Why?
|
| Female | 62 | 2024 | 46617 | 0.800 |
Why?
|
| Male | 61 | 2024 | 42705 | 0.800 |
Why?
|
| Atrioventricular Block | 4 | 2024 | 25 | 0.770 |
Why?
|
| Prospective Studies | 22 | 2024 | 4329 | 0.760 |
Why?
|
| Heart Atria | 3 | 2020 | 282 | 0.700 |
Why?
|
| Ventricular Function, Left | 8 | 2024 | 613 | 0.700 |
Why?
|
| Anticoagulants | 2 | 2023 | 432 | 0.690 |
Why?
|
| Purkinje Fibers | 1 | 2019 | 27 | 0.650 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2019 | 25 | 0.650 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2019 | 72 | 0.630 |
Why?
|
| Action Potentials | 3 | 2024 | 601 | 0.580 |
Why?
|
| Atrioventricular Node | 5 | 2024 | 35 | 0.570 |
Why?
|
| Cicatrix | 4 | 2024 | 68 | 0.560 |
Why?
|
| Retrospective Studies | 25 | 2024 | 9237 | 0.550 |
Why?
|
| Ventricular Function, Right | 1 | 2017 | 150 | 0.540 |
Why?
|
| Atrial Flutter | 4 | 2020 | 36 | 0.520 |
Why?
|
| Spinal Cord Stimulation | 1 | 2015 | 16 | 0.510 |
Why?
|
| Surgical Procedures, Operative | 1 | 2018 | 206 | 0.500 |
Why?
|
| Hospitalization | 4 | 2018 | 888 | 0.480 |
Why?
|
| Cause of Death | 1 | 2015 | 269 | 0.460 |
Why?
|
| Ventricular Fibrillation | 4 | 2024 | 68 | 0.430 |
Why?
|
| Incidence | 7 | 2024 | 1604 | 0.410 |
Why?
|
| Streptococcal Infections | 1 | 2012 | 56 | 0.410 |
Why?
|
| Myocarditis | 1 | 2012 | 51 | 0.400 |
Why?
|
| Equipment Failure | 1 | 2012 | 122 | 0.400 |
Why?
|
| Bradycardia | 2 | 2022 | 40 | 0.390 |
Why?
|
| Postoperative Complications | 3 | 2021 | 2316 | 0.390 |
Why?
|
| Risk Factors | 14 | 2024 | 5562 | 0.380 |
Why?
|
| Growth Differentiation Factor 10 | 1 | 2011 | 1 | 0.380 |
Why?
|
| Registries | 3 | 2024 | 808 | 0.380 |
Why?
|
| Antigens, Ly | 1 | 2011 | 37 | 0.370 |
Why?
|
| Follow-Up Studies | 14 | 2021 | 3684 | 0.370 |
Why?
|
| Epicardial Mapping | 2 | 2021 | 10 | 0.360 |
Why?
|
| Ventricular Dysfunction, Left | 5 | 2014 | 332 | 0.360 |
Why?
|
| Sick Sinus Syndrome | 2 | 2021 | 9 | 0.350 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2011 | 127 | 0.350 |
Why?
|
| Ventricular Remodeling | 7 | 2020 | 108 | 0.340 |
Why?
|
| Monitoring, Physiologic | 1 | 2011 | 266 | 0.340 |
Why?
|
| Device Removal | 2 | 2021 | 168 | 0.320 |
Why?
|
| Transforming Growth Factor beta | 1 | 2011 | 326 | 0.320 |
Why?
|
| Mitral Valve | 3 | 2020 | 264 | 0.300 |
Why?
|
| GTPase-Activating Proteins | 1 | 2008 | 67 | 0.300 |
Why?
|
| Wnt Proteins | 1 | 2008 | 130 | 0.290 |
Why?
|
| Prosthesis Implantation | 3 | 2021 | 129 | 0.290 |
Why?
|
| Predictive Value of Tests | 7 | 2024 | 1732 | 0.290 |
Why?
|
| Time Factors | 8 | 2024 | 5361 | 0.290 |
Why?
|
| Aged, 80 and over | 11 | 2024 | 6787 | 0.280 |
Why?
|
| beta Catenin | 1 | 2008 | 267 | 0.270 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2007 | 128 | 0.270 |
Why?
|
| Myocardial Ischemia | 4 | 2019 | 164 | 0.260 |
Why?
|
| Ventricular Septum | 2 | 2024 | 14 | 0.260 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2020 | 164 | 0.260 |
Why?
|
| Cohort Studies | 5 | 2019 | 2887 | 0.260 |
Why?
|
| Risk Assessment | 7 | 2024 | 2327 | 0.240 |
Why?
|
| Myocardium | 2 | 2020 | 573 | 0.240 |
Why?
|
| Membrane Proteins | 1 | 2011 | 1227 | 0.230 |
Why?
|
| Lower Gastrointestinal Tract | 1 | 2004 | 8 | 0.230 |
Why?
|
| Patient Selection | 2 | 2022 | 682 | 0.230 |
Why?
|
| Hemodynamics | 2 | 2024 | 738 | 0.230 |
Why?
|
| Esophageal Fistula | 1 | 2023 | 11 | 0.220 |
Why?
|
| Survival Rate | 3 | 2024 | 1899 | 0.220 |
Why?
|
| Electrodes, Implanted | 3 | 2012 | 185 | 0.220 |
Why?
|
| Mental Health | 1 | 2024 | 180 | 0.210 |
Why?
|
| Influenza Vaccines | 1 | 2024 | 150 | 0.210 |
Why?
|
| Medicare | 3 | 2024 | 427 | 0.200 |
Why?
|
| United States | 8 | 2024 | 7114 | 0.200 |
Why?
|
| Heart-Assist Devices | 4 | 2018 | 807 | 0.200 |
Why?
|
| Vaccination | 1 | 2024 | 279 | 0.200 |
Why?
|
| Feasibility Studies | 6 | 2021 | 785 | 0.200 |
Why?
|
| Ventricular Premature Complexes | 1 | 2021 | 8 | 0.200 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 435 | 0.200 |
Why?
|
| Machine Learning | 1 | 2024 | 270 | 0.190 |
Why?
|
| Prognosis | 5 | 2023 | 3800 | 0.190 |
Why?
|
| Treatment Failure | 3 | 2017 | 278 | 0.190 |
Why?
|
| Recurrence | 6 | 2024 | 1147 | 0.190 |
Why?
|
| Crohn Disease | 2 | 2007 | 764 | 0.180 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2021 | 10 | 0.180 |
Why?
|
| Prosthesis-Related Infections | 1 | 2021 | 61 | 0.180 |
Why?
|
| Electrophysiology | 1 | 2021 | 403 | 0.180 |
Why?
|
| Pulmonary Veins | 2 | 2012 | 93 | 0.180 |
Why?
|
| Gadolinium | 1 | 2020 | 103 | 0.180 |
Why?
|
| Global Health | 2 | 2021 | 193 | 0.180 |
Why?
|
| Infection Control | 1 | 2021 | 124 | 0.170 |
Why?
|
| Severity of Illness Index | 4 | 2019 | 1863 | 0.170 |
Why?
|
| Vena Cava, Superior | 1 | 2020 | 60 | 0.170 |
Why?
|
| Ultrasonography, Interventional | 1 | 2020 | 124 | 0.170 |
Why?
|
| Cardiac Catheters | 1 | 2019 | 13 | 0.160 |
Why?
|
| Cardiac Catheterization | 2 | 2018 | 307 | 0.160 |
Why?
|
| Single-Blind Method | 1 | 2019 | 151 | 0.160 |
Why?
|
| Tachycardia | 1 | 2018 | 37 | 0.150 |
Why?
|
| Computer Security | 1 | 2018 | 17 | 0.150 |
Why?
|
| Inferior Wall Myocardial Infarction | 1 | 2018 | 2 | 0.150 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 332 | 0.150 |
Why?
|
| Myocardial Contraction | 1 | 2019 | 252 | 0.150 |
Why?
|
| Quality of Life | 2 | 2024 | 1682 | 0.140 |
Why?
|
| Intensive Care Units | 1 | 2021 | 398 | 0.140 |
Why?
|
| Thromboembolism | 1 | 2018 | 122 | 0.140 |
Why?
|
| Forecasting | 2 | 2015 | 304 | 0.140 |
Why?
|
| Cardiology | 1 | 2017 | 115 | 0.140 |
Why?
|
| Glomerular Filtration Barrier | 1 | 2015 | 1 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 799 | 0.130 |
Why?
|
| Coronary Angiography | 2 | 2014 | 244 | 0.120 |
Why?
|
| Disease-Free Survival | 5 | 2017 | 1169 | 0.120 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2014 | 33 | 0.110 |
Why?
|
| Societies, Medical | 1 | 2017 | 584 | 0.110 |
Why?
|
| Cardiac Conduction System Disease | 2 | 2023 | 7 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2017 | 457 | 0.110 |
Why?
|
| Heart Valve Diseases | 1 | 2014 | 116 | 0.110 |
Why?
|
| Walking | 1 | 2014 | 93 | 0.110 |
Why?
|
| Pharyngitis | 1 | 2012 | 15 | 0.100 |
Why?
|
| Streptococcus pyogenes | 1 | 2012 | 35 | 0.100 |
Why?
|
| Animals | 4 | 2022 | 27536 | 0.100 |
Why?
|
| Creatine Kinase | 1 | 2012 | 52 | 0.100 |
Why?
|
| Heart Failure, Systolic | 1 | 2012 | 5 | 0.100 |
Why?
|
| Chest Pain | 1 | 2012 | 42 | 0.100 |
Why?
|
| Troponin T | 1 | 2012 | 39 | 0.100 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2014 | 179 | 0.100 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 222 | 0.100 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 189 | 0.100 |
Why?
|
| Motor Activity | 1 | 2014 | 327 | 0.090 |
Why?
|
| Prosthesis Design | 2 | 2024 | 300 | 0.090 |
Why?
|
| Tachycardia, Paroxysmal | 1 | 2011 | 2 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 1255 | 0.090 |
Why?
|
| Smad3 Protein | 1 | 2011 | 25 | 0.090 |
Why?
|
| Equipment Design | 1 | 2012 | 422 | 0.090 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2011 | 45 | 0.090 |
Why?
|
| RNA, Neoplasm | 1 | 2011 | 88 | 0.090 |
Why?
|
| Renal Dialysis | 1 | 2013 | 338 | 0.090 |
Why?
|
| Adult | 7 | 2021 | 26836 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 309 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 1 | 2014 | 366 | 0.090 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2011 | 99 | 0.080 |
Why?
|
| Surveys and Questionnaires | 4 | 2024 | 2658 | 0.080 |
Why?
|
| Patient Care Team | 1 | 2012 | 284 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 414 | 0.080 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 380 | 0.080 |
Why?
|
| Biomarkers | 2 | 2012 | 1778 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2011 | 3404 | 0.080 |
Why?
|
| Axin Protein | 1 | 2008 | 4 | 0.080 |
Why?
|
| Young Adult | 3 | 2021 | 6418 | 0.080 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2008 | 44 | 0.080 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2008 | 48 | 0.080 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2008 | 69 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 1606 | 0.080 |
Why?
|
| Cytosol | 1 | 2008 | 193 | 0.070 |
Why?
|
| Age Factors | 1 | 2012 | 1880 | 0.070 |
Why?
|
| Contrast Media | 2 | 2024 | 1084 | 0.070 |
Why?
|
| Base Sequence | 1 | 2011 | 2329 | 0.070 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 1579 | 0.070 |
Why?
|
| Behavior | 1 | 2007 | 85 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 2770 | 0.070 |
Why?
|
| Interprofessional Relations | 1 | 2007 | 121 | 0.070 |
Why?
|
| Perception | 1 | 2007 | 179 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2014 | 855 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2011 | 2016 | 0.070 |
Why?
|
| Clinical Clerkship | 1 | 2007 | 118 | 0.070 |
Why?
|
| Mice | 2 | 2011 | 11858 | 0.060 |
Why?
|
| Zebrafish | 1 | 2008 | 322 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 1284 | 0.060 |
Why?
|
| Comorbidity | 2 | 2021 | 953 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2008 | 424 | 0.060 |
Why?
|
| Ethics, Medical | 1 | 2007 | 306 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2011 | 2026 | 0.060 |
Why?
|
| Ventricular Pressure | 1 | 2024 | 41 | 0.060 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2024 | 10 | 0.060 |
Why?
|
| Prevalence | 2 | 2018 | 1250 | 0.060 |
Why?
|
| Heart Injuries | 1 | 2024 | 19 | 0.060 |
Why?
|
| Syncope | 1 | 2024 | 34 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 2018 | 0.060 |
Why?
|
| Fluoroscopy | 1 | 2024 | 127 | 0.060 |
Why?
|
| Models, Biological | 1 | 2011 | 1766 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 3253 | 0.060 |
Why?
|
| Cell Line | 1 | 2008 | 2495 | 0.060 |
Why?
|
| Atropine | 1 | 2023 | 60 | 0.060 |
Why?
|
| Secondary Prevention | 1 | 2024 | 159 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 1181 | 0.060 |
Why?
|
| Heart Block | 1 | 2023 | 31 | 0.060 |
Why?
|
| Constriction, Pathologic | 1 | 2004 | 222 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2021 | 1868 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2023 | 173 | 0.050 |
Why?
|
| Health Status | 1 | 2024 | 371 | 0.050 |
Why?
|
| Students, Medical | 1 | 2007 | 425 | 0.050 |
Why?
|
| Confidence Intervals | 2 | 2012 | 221 | 0.050 |
Why?
|
| Mortality | 1 | 2021 | 149 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2024 | 866 | 0.040 |
Why?
|
| Endocardium | 1 | 2020 | 98 | 0.040 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 30 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2014 | 359 | 0.040 |
Why?
|
| Disease Progression | 2 | 2014 | 1469 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2012 | 1497 | 0.040 |
Why?
|
| Pericardium | 1 | 2019 | 70 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 1704 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2017 | 115 | 0.030 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2017 | 56 | 0.030 |
Why?
|
| Heart | 1 | 2020 | 578 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2017 | 202 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 603 | 0.030 |
Why?
|
| Cardio-Renal Syndrome | 1 | 2015 | 6 | 0.030 |
Why?
|
| Boston | 1 | 2015 | 37 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2014 | 55 | 0.030 |
Why?
|
| Tissue Survival | 1 | 2014 | 13 | 0.030 |
Why?
|
| Capillaries | 1 | 2014 | 90 | 0.030 |
Why?
|
| Massachusetts | 1 | 2013 | 33 | 0.030 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2014 | 47 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2014 | 94 | 0.030 |
Why?
|
| Cardiac Output | 1 | 2012 | 155 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 1082 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 305 | 0.020 |
Why?
|
| Child | 1 | 2023 | 7242 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 848 | 0.020 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2011 | 22 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2012 | 187 | 0.020 |
Why?
|
| Adolescent | 1 | 2004 | 9347 | 0.020 |
Why?
|
| Risk | 1 | 2012 | 657 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 872 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2013 | 958 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 983 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 841 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2014 | 731 | 0.020 |
Why?
|
| Observation | 1 | 2007 | 38 | 0.020 |
Why?
|
| Italy | 1 | 2007 | 108 | 0.020 |
Why?
|
| Japan | 1 | 2007 | 304 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2011 | 1134 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2007 | 899 | 0.020 |
Why?
|
| Reoperation | 1 | 2007 | 605 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2007 | 654 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2007 | 625 | 0.010 |
Why?
|